Yves Chrétien Selected Research

Yves Chrétien Research Topics

Disease

12	Neoplasms (Cancer) 04/2021 - 07/2002
5	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 08/2002
4	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 09/2008 - 06/2004
3	Cholelithiasis 04/2021 - 09/2013
2	Cholestasis 01/2020 - 12/2008
2	Cholangiocarcinoma 08/2016 - 08/2014
2	Pruritus (Itching) 07/2010 - 07/2010
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2021
1	Gallstones (Gallstone) 04/2021
1	Lithiasis 04/2021
1	Overweight 04/2021
1	Cholecystitis 04/2021
1	Acute Cholecystitis 04/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Intrahepatic Cholestasis 01/2020
1	Intrahepatic Cholestasis of Pregnancy 01/2020
1	Fatty Liver 01/2020
1	Inflammation (Inflammations) 12/2018
1	Dysbiosis 12/2018
1	Virus Diseases (Viral Diseases) 11/2016
1	Hepatitis B 11/2016
1	Carcinogenesis 08/2016
1	Cholangitis 07/2010
1	Urinary Tract Infections (Urinary Tract Infection) 07/2010
1	End Stage Liver Disease 07/2010
1	Thyroid Diseases (Thyroid Disease) 07/2010
1	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 06/2009
1	Liver Diseases (Liver Disease) 12/2008
1	Hepatitis 09/2008
1	Type 2 Diabetes Mellitus (MODY) 03/2005
1	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 03/2005
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2005
1	Mason-Type Diabetes 03/2005
1	Fibrosis (Cirrhosis) 06/2004
1	Necrosis 06/2004
1	Liver Cirrhosis (Hepatic Cirrhosis) 06/2004
1	Infections 02/2002

Drug/Important Bio-Agent (IBA)

5	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 12/2008 - 06/2004
3	Phospholipids (Phosphatides)FDA LinkGeneric 04/2021 - 09/2013
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2004
2	Insulin ReceptorIBA 01/2019 - 07/2013
2	Messenger RNA (mRNA)IBA 11/2016 - 03/2005
2	Insulin (Novolin)FDA Link 11/2016 - 09/2016
2	BilirubinIBA 09/2008 - 06/2004
1	Adenosine Triphosphate (ATP)IBA 04/2021
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 04/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Trastuzumab (Herceptin)FDA Link 01/2020
1	Contraceptive Agents (Contraceptives)IBA 01/2020
1	LipidsIBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Bile Acids and Salts (Bile Acids)IBA 12/2018
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 12/2018
1	Neuregulin-1 (Neuregulin 1)IBA 11/2016
1	Cadherins (E-Cadherin)IBA 08/2016
1	ezrinIBA 08/2016
1	Epidermal Growth Factor (EGF)IBA 08/2014
1	RNA Splicing FactorsIBA 07/2013
1	RNA Precursors (Precursor, mRNA)IBA 07/2013
1	Tobacco Smoke Pollution (Passive Smoking)IBA 07/2010
1	Oral ContraceptivesIBA 07/2010
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2009
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2008
1	Chloride-Bicarbonate AntiportersIBA 12/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2008
1	Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA 03/2005
1	Transcription Factors (Transcription Factor)IBA 03/2005
1	Hepatocyte Nuclear FactorsIBA 03/2005
1	UromodulinIBA 03/2005
1	Aligeron (AS 2)IBA 09/2003
1	Ganciclovir (Cytovene)FDA LinkGeneric 08/2002
1	Thymidine KinaseIBA 08/2002
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 08/2002
1	Prostate-Specific Antigen (Semenogelase)IBA 07/2002
1	P-2 (P 2)IBA 07/2002
1	Apolipoprotein A-II (Apolipoprotein A2)IBA 02/2002

Therapy/Procedure

5	Therapeutics 06/2021 - 06/2004
2	Transplantation 07/2010 - 01/2004
1	Conservative Treatment 06/2021
1	Cholecystectomy 04/2021
1	Cystectomy 01/2003
1	Prostatectomy (Retropubic Prostatectomy) 07/2002